國立高雄大學圖資館 |

Language: English

Back

Cannabis and cannabinoid-based medicines in cancer carea comprehensive guide to medical management /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cannabis and cannabinoid-based medicines in cancer careby Claude Cyr ... [et al.].
Reminder of title:	a comprehensive guide to medical management /
other author:	Cyr, Claude.
Published:	Cham :Springer International Publishing :2022.
Description:	xxvii, 308 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	CancerTreatment.
Online resource:	https://doi.org/10.1007/978-3-030-89918-9
ISBN:	9783030899189$q(electronic bk.)

Cannabis and cannabinoid-based medicines in cancer carea comprehensive guide to medical management /
Cannabis and cannabinoid-based medicines in cancer carea comprehensive guide to medical management /[electronic resource] :by Claude Cyr ... [et al.]. - Cham :Springer International Publishing :2022. - xxvii, 308 p. :ill., digital ;24 cm.

Overview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry.

The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis' disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.

ISBN: 9783030899189$q(electronic bk.)

Standard No.: 10.1007/978-3-030-89918-9doiSubjects--Topical Terms:

252269
Cancer
--Treatment.

LC Class. No.: RC271.A62

Dewey Class. No.: 616.99406

Cannabis and cannabinoid-based medicines in cancer carea comprehensive guide to medical management /
LDR:03588nmm a2200325 a 4500 001 623222
003 DE-He213
005 20220211122359.0
006 m d
007 cr nn 008maaau
008 221209s2022 sz s 0 eng d
020 $a 9783030899189$q(electronic bk.)
020 $a 9783030899172$q(paper)
024 7 $a 10.1007/978-3-030-89918-9 $2 doi
035 $a 978-3-030-89918-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.A62
072 7 $a MJ $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC271.A62 $b C224 2022
245 0 0 $a Cannabis and cannabinoid-based medicines in cancer care $h [electronic resource] : $b a comprehensive guide to medical management / $c by Claude Cyr ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xxvii, 308 p. : $b ill., digital ; $c 24 cm.
505 0 $a Overview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry.
520 $a The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis' disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings.
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Cancer $x Alternative treatment. $3 276774
650 0 $a Cannabinoids $x Therapeutic use. $3 846333
650 1 4 $a Internal Medicine. $3 273839
650 2 4 $a Pain Medicine. $3 276762
650 2 4 $a Palliative Care. $3 293434
700 1 $a Cyr, Claude. $3 925330
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-89918-9
950 $a Medicine (SpringerNature-11650)